SAVIMS

SAVIMS logo white
Menu

Resource Type

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

The Impact of the Johnson & Johnson Vaccine on Thrombus Risk in Hypercoagulable Patients

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Rutenberg, D., & Zhang, Y. (2021). The clot thickens: Does the Johnson & Johnson COVID-19 vaccine increase the risk of thrombus in a hypercoagulable state? Chest, 2195. https://doi.org/10.1016/j.chest.2021.07.1937 Summary: Since January 2020, Elsevier has provided a COVID-19 resource centre offering free access to information on the novel coronavirus. The resource centre allows unrestricted sharing […]

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Treatment Protocols for COVID-19: A Focus on Early Intervention

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Front Line COVID-19 Critical Care Alliance. (2021). Prevention & treatment protocols for COVID-19. Retrieved from https://flccc.net Summary: The Front Line COVID-19 Critical Care Alliance (FLCCC) has established a comprehensive treatment protocol, MATH+, aimed at addressing the severe inflammatory response in COVID-19 patients. This protocol recommends a combination of medications, including methylprednisolone, ascorbic acid, thiamine,

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Prevention and Early Outpatient Treatment Protocol for COVID-19

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Front Line COVID-19 Critical Care Alliance. (2021). Prevention & early outpatient treatment protocol for COVID-19. FLCCC Alliance. https://www.flccc.net Summary: The FLCCC Alliance’s I-MASK+ protocol outlines a comprehensive approach to preventing and treating COVID-19, particularly for high-risk individuals. Prevention measures include administering Ivermectin at a dosage of 0.2 mg/kg, Vitamin D3, Vitamin C, Quercetin, Zinc,

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Identifying Graphene Oxide in Aqueous Suspension: A Microscopic Study

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Campra, P. (2021). Graphene oxide detection in aqueous suspension: Observational study in optical and electron microscopy. Interim report (I). Universidad de Almería, Spain. Summary: This interim report details the microscopic analysis of a vial labelled “COMIRNATY™,” containing a cloudy aqueous suspension. Received on 06/10/2021, the sample underwent RNA extraction and quantification, revealing the presence

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

A Comprehensive Guide to Home-Based COVID Treatment

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Association of American Physicians and Surgeons. (2021). A guide to home-based COVID treatment: Step-by-step doctors’ plan that could save your life. AAPS. Retrieved from https://aapsonline.org Summary: The “Guide to Home-Based COVID Treatment” provided by the Association of American Physicians and Surgeons (AAPS) is a resource aimed at educating patients on managing COVID-19 symptoms at

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Update on SARS-CoV-2 Variants of Concern in England

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Public Health England. (2021). SARS-CoV-2 variants of concern and variants under investigation in England: Technical briefing 17 (25 June 2021). Retrieved from https://www.gov.uk/phe Summary: The Technical Briefing 17 from Public Health England, dated 25 June 2021, reports on the surveillance of SARS-CoV-2 variants in England. As of that date, there are four variants of

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Understanding the Pfizer-BioNTech COVID-19 Vaccine: What You Need to Know

| | COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: U.S. Department of Health and Human Services. (2021). Fact sheet for recipients and caregivers: Emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 12 years of age and older. Retrieved from www.cvdvaccine.com Summary: The Pfizer-BioNTech COVID-19 Vaccine is offered under emergency use authorization (EUA) to prevent

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Comprehensive Overview of the FLCCC COVID-19 Management Protocol

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Marik, P. (2021). FLCCC Alliance – COVID-19 Management Protocol (06-21-2021). Retrieved from www.flccc.net Summary: The FLCCC Alliance’s COVID-19 Management Protocol provides a multifaceted approach to treating COVID-19, focusing on prevention and early intervention to mitigate severe disease outcomes. The protocol outlines three key treatment strategies: MATH+, I-MASK+, and I-RECOVER, tailored to different stages of

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety of mRNA Covid-19 Vaccines in Pregnant Persons Supplementary appendix

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C. K., Liu, R., Chang, K. T., Ellington, S. R., Burkel, V. K., Smoots, A. N., Green, C. J., Licata, C., Zhang, B. C., Alimchandani, M., Mba-Jonas, A., Martin, S. W., Gee, J. M.,

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety of mRNA Covid-19 Vaccines in Pregnant Persons

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., … & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine, 384(24), 2273-2282. https://doi.org/10.1056/NEJMoa2104983 Summary: The article evaluates the safety of mRNA Covid-19 vaccines in pregnant individuals, utilising

Scroll to Top